Comprehensive Binary Interaction Mapping of SH2 Domains via Fluorescence Polarization Reveals Novel Functional Diversification of ErbB Receptors

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Hause, Ronald J ^a   Leung, Kin K ^a   Barkinge, John L ^a   Ciaccio, Mark F ^a   Chuu, Chih pin ^b   Jones, Richard B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PHOSPHATIDYLINOSITOL KINASE; POLYPHOSPHOINOSITIDE; PROTEIN TYROSINE KINASE; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FLUORESCENCE POLARIZATION; MOLECULAR INTERACTION; PHOSPHOTYROSINE BINDING DOMAIN; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SRC HOMOLOGY 2 DOMAIN; SRC HOMOLOGY DOMAIN;

CHROMATOGRAPHY, GEL; FLUORESCENCE POLARIZATION; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; PROTEIN INTERACTION MAPPING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SRC HOMOLOGY DOMAINS; SURFACE PLASMON RESONANCE;

EID: 84866052943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044471     Document Type: Article

References (55)

1. Bublil EM, Yarden Y, (2007) The EGF receptor family: spearheading a merger of signaling and therapeutics. Current opinion in cell biology 19: 124-134.
2. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, et al. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418-425 doi:10.1038/309418a0.
3. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, et al. (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319: 230-234 doi:10.1038/319230a0.
4. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA, (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A 86: 9193-9197.
5. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, et al. (1990) Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proceedings of the National Academy of Sciences of the United States of America 87: 4905-4909.
6. Plowman GD, Green JM, Culouscou J-M, Carlton GW, Rothwell VM, et al. (1993) Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 366: 473-475 doi:10.1038/366473a0.
7. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T, (1986) The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644-1646 doi:10.1126/science.3012781.
8. Graus-Porta D, Beerli RR, Daly JM, Hynes NE, (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16: 1647-1655 doi:10.1093/emboj/16.7.1647.
9. Shi F, Telesco SE, Liu Y, Radhakrishnan R, Lemmon MA, (2010) ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proceedings of the National Academy of Sciences 107: 7692-7697 doi:10.1073/pnas.1002753107.
10. Sadowski I, Stone JC, Pawson T, (1986) A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Molecular and cellular biology 6: 4396-4408.
11. Koch C, Anderson D, Moran M, Ellis C, Pawson T, (1991) SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252: 668-674 doi:10.1126/science.1708916.
12. Pawson T, Gish GD, Nash P, (2001) SH2 domains, interaction modules and cellular wiring. Trends in cell biology 11: 504-511.
13. Kavanaugh WM, Williams LT, (1994) An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266: 1862-1865.
14. Schlessinger J, Lemmon MA, (2003) SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 2003: RE12.
15. Hsieh M, Yang S, Raymond-Stinz M, Edwards J, Wilson B, (2010) Spatio-temporal modeling of signaling protein recruitment to EGFR. BMC Systems Biology 4: 57 doi:10.1186/1752-0509-4-57.
16. Hynes NE, Lane HA, (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341-354 doi:nrc1609.
17. Hynes NE, MacDonald G, (2009) ErbB receptors and signaling pathways in cancer. Current Opinion in Cell Biology 21: 177-184 doi:10.1016/j.ceb.2008.12.010.
18. Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E, Zhang B, (2004) PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. PROTEOMICS 4: 1551-1561 doi:10.1002/pmic.200300772.
19. Diella F, Cameron S, Gemund C, Linding R, Via A, et al. (2004) Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC bioinformatics 5: 79.
20. Dinkel H, Chica C, Via A, Gould CM, Jensen LJ, et al. (2011) Phospho.ELM: a database of phosphorylation sites-update 2011. Nucleic Acids Res 39: D261-D267 doi:10.1093/nar/gkq1104.
21. Gronborg M, Ibarrola N, Deshpande N, Shanker K, Shivashankar HN, et al. (2003) Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome research 13: 2363-2371.
22. Zheng X-M, Resnick RJ, Shalloway D, (2000) A phosphotyrosine displacement mechanism for activation of Src by PTP[alpha]. EMBO J 19: 964-978 doi:10.1093/emboj/19.5.964.
23. Kaimachnikov NP, Kholodenko BN, (2009) Toggle switches, pulses and oscillations are intrinsic properties of the Src activation/deactivation cycle. FEBS Journal 276: 4102-4118 doi:10.1111/j.1742-4658.2009.07117.x.
24. Shalloway D, Taylor S, (1997) Src: more than the sum of its parts. Trends in Cell Biology 7: 215-217 doi:10.1016/S0962-8924(97)01063-5.
25. Ji Q, Chattopadhyay A, Vecchi M, Carpenter G, (1999) Physiological Requirement for Both SH2 Domains for Phospholipase C-gamma 1 Function and Interaction with Platelet-Derived Growth Factor Receptors. Mol Cell Biol 19: 4961-4970.
26. Waterfield MD, Panayotou G, Gish G, End P, Truong O, et al. (1993) Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach. Mol Cell Biol 13: 3567-3576.
27. Felder S, Zhou M, Hu P, Urena J, Ullrich A, et al. (1993) SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Molecular and cellular biology 13: 1449-1455.
28. Lubman OY, Waksman G, (2003) Structural and thermodynamic basis for the interaction of the Src SH2 domain with the activated form of the PDGF beta-receptor. Journal of molecular biology 328: 655-668.
29. Lemmon MA, Ladbury JE, (1994) Thermodynamic studies of tyrosyl-phosphopeptide binding to the SH2 domain of p56lck. Biochemistry 33: 5070-5076 doi:7513553.
30. Ladbury JE, Lemmon MA, Zhou M, Green J, Botfield MC, et al. (1995) Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc Natl Acad Sci U S A 92: 3199-3203 doi:PMC42133.
31. Zhou S, Shoelson SE, Chaudhuri M, Gish G, Pawson T, et al. (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778 doi:10.1016/0092-8674(93)90404-E.
32. Huang H, Li L, Wu C, Schibli D, Colwill K, et al. (2008) Defining the specificity space of the human SRC homology 2 domain. Mol Cell Proteomics 7: 768-784 doi:10.1074/mcp.M700312-MCP200.
33. Liu BA, Jablonowski K, Shah EE, Engelmann BW, Jones RB, et al. (2010) SH2 domains recognize contextual peptide sequence information to determine selectivity. Molecular & Cellular Proteomics. doi:10.1074/mcp.M110.001586.
34. Jones RB, Gordus A, Krall JA, MacBeath G, (2006) A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439: 168-174.
35. Kaushansky A, Gordus A, Budnik BA, Lane WS, Rush J, et al. (2008) System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties. Chem Biol 15: 808-817 doi:10.1016/j.chembiol.2008.07.006.
36. Kaushansky A, Gordus A, Chang B, Rush J, MacBeath G, (2008) A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. Mol Biosyst 4: 643-653 doi:10.1039/b801018h.
37. Bibbins KB, Boeuf H, Varmus HE, (1993) Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides. Mol Cell Biol 13: 7278-7287.
38. Lynch BA, Loiacono KA, Tiong CL, Adams SE, MacNeil IA, (1997) A fluorescence polarization based Src-SH2 binding assay. Anal Biochem 247: 77-82 doi:10.1006/abio.1997.2042.
39. Stiffler MA, Chen JR, Grantcharova VP, Lei Y, Fuchs D, et al. (2007) PDZ domain binding selectivity is optimized across the mouse proteome. Science 317: 364-369 doi:10.1126/science.1144592.
40. Kaushansky A, Allen JE, Gordus A, Stiffler MA, Karp ES, et al. (2010) Quantifying protein-protein interactions in high throughput using protein domain microarrays. Nat Protocols 5: 773-790 doi:10.1038/nprot.2010.36.
41. Ritz C, Streibig JC, (2005) Bioassay Analysis Using R. Journal of Statistical Software. 12: 1-22.
42. Nikolovska-Coleska Z, Wang R, Fang X, Pan H, Tomita Y, et al. (2004) Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. Analytical Biochemistry 332: 261-273 doi:16/j.ab.2004.05.055.
43. Stiffler MA, Grantcharova VP, Sevecka M, MacBeath G, (2006) Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays. Journal of the American Chemical Society 128: 5913-5922.
44. Zhang Chung, (1999) Oldenburg (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67-73.
45. Sundvall M, Veikkolainen V, Kurppa K, Salah Z, Tvorogov D, et al. (2010) Cell Death or Survival Promoted by Alternative Isoforms of ErbB4. Mol Biol Cell 21: 4275-4286 doi:10.1091/mbc.E10-04-0332.
46. Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, et al. (2004) The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 167: 469-478 doi:10.1083/jcb.200403155.
47. Fiddes RJ, Campbell DH, Janes PW, Sivertsen SP, Sasaki H, et al. (1998) Analysis of Grb7 Recruitment by Heregulin-activated erbB Receptors Reveals a Novel Target Selectivity for erbB3. J Biol Chem 273: 7717-7724 doi:10.1074/jbc.273.13.7717.
48. Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, et al. (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25: 25-29 doi:10.1038/75556.
49. Zhang Y, Wolf-Yadlin A, Ross PL, Pappin DJ, Rush J, et al. (2005) Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules. Molecular & Cellular Proteomics 4: 1240-1250 doi:10.1074/mcp.M500089-MCP200.
50. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, et al. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-648.
51. Wolf-Yadlin A, Kumar N, Zhang Y, Hautaniemi S, Zaman M, et al. (2006) Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Molecular systems biology 2: 54.
52. Ciaccio MF, Wagner JP, Chuu C-P, Lauffenburger DA, Jones RB, (2010) Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nature Methods 7: 148-155 doi:10.1038/nmeth.1418.
53. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, et al. (1995) Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10: 1813-1821.
54. Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, et al. (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 15: 2452-2467.
55. Liu BA, Jablonowski K, Raina M, Arce M, Pawson T, et al. (2006) The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Molecular cell 22: 851-868.